Real-time continuous glucose monitoring in preterm infants (REACT): an international, open-label, randomised controlled trial
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Hyperglycaemia and hypoglycaemia are common in preterm infants and have been associated with increased risk of mortality and morbidity. Interventions to reduce risk associated with these exposures are particularly challenging due to the infrequent measurement of blood glucose concentrations, with the potential of causing more harm instead of improving outcomes for these infants. Continuous glucose monitoring (CGM) is widely used in adults and children with diabetes to improve glucose control, but has not been approved for use in neonates. The REACT trial aimed to evaluate the efficacy and safety of CGM in preterm infants requiring intensive care. METHODS: This international, open-label, randomised controlled trial was done in 13 neonatal intensive care units in the UK, Spain, and the Netherlands. Infants were included if they were within 24 h of birth, had a birthweight of 1200 g or less, had a gestational age up to 33 weeks plus 6 days, and had parental written informed consent. Infants were randomly assigned (1:1) to real-time CGM or standard care (with masked CGM for comparison) using a central web randomisation system, stratified by recruiting centre and gestational age (<26 or ≥26 weeks). The primary efficacy outcome was the proportion of time sensor glucose concentration was 2·6-10 mmol/L for the first week of life. Safety outcomes related to hypoglycaemia (glucose concentrations <2·6 mmol/L) in the first 7 days of life. All outcomes were assessed on the basis of intention to treat in the full analysis set with available data. The study is registered with the International Standard Randomised Control Trials Registry, ISRCTN12793535. FINDINGS: Between July 4, 2016, and Jan 27, 2019, 182 infants were enrolled, 180 of whom were randomly assigned (85 to real-time CGM, 95 to standard care). 70 infants in the real-time CGM intervention group and 85 in the standard care group had CGM data and were included in the primary analysis. Compared with infants in the standard care group, infants managed using CGM had more time in the 2·6-10 mmol/L glucose concentration target range (mean proportion of time 84% [SD 22] vs 94% [11]; adjusted mean difference 8·9% [95% CI 3·4-14·4]), equivalent to 13 h (95% CI 5-21). More infants in the standard care group were exposed to at least one episode of sensor glucose concentration of less than 2·6 mmol/L for more than 1 h than those in the intervention group (13 [15%] of 85 vs four [6%] of 70). There were no serious adverse events related to the use of the device or episodes of infection. INTERPRETATION: Real-time CGM can reduce exposure to prolonged or severe hyperglycaemia and hypoglycaemia. Further studies using CGM are required to determine optimal glucose targets, strategies to obtain them, and the potential effect on long-term health outcomes. FUNDING: National Institute for Health Research Efficacy and Mechanisms Evaluation Programme.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0028 · Cited by 4,237
Self-citationHyperglycemia drives intestinal barrier dysfunction and risk for enteric infection
Thaiss, C. A., Levy, M., Grosheva, I., Zheng, D., Soffer, E., Blacher, E., Braverman, S., Tengeler, A. C., Barak, O., Elazar, M., et al. (2018) · Science · doi:10.1126/science.aar3318 · Cited by 942
Association of neonatal glycemia with neurodevelopmental outcomes at 4.5 years
McKinlay, C. J. D., Alsweiler, J. M., Anstice, N. S., Burakevych, N., Chakraborty, A., Chase, J. G., Gamble, G. D., Harris, D. L., Jacobs, R. J., Jiang, Y., et al. (2017) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2017.1579 · Cited by 395
Validation of the continuous glucose monitoring sensor in preterm infants
Beardsall, K., Vanhaesebrouck, S., Ogilvy-Stuart, A. L., Vanhole, C., vanWeissenbruch, M., Midgley, P., Thio, M., Cornette, L., Ossuetta, I., Palmer, C. R., et al. (2013) · Archives of Disease in Childhood - Fetal and Neonatal Edition · doi:10.1136/archdischild-2012-301661 · Cited by 82
Self-citation
Cited by
Use of Continuous Glucose Monitors by People Without Diabetes: An Idea Whose Time Has Come?
Klonoff, D. C., Nguyen, K. T., Xu, N. Y., Gutierrez, A., Espinoza, J. C., & Vidmar, A. P. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221110830 · Cited by 93
The History, Evolution and Future of Continuous Glucose Monitoring (CGM)
Bender, C., Vestergaard, P., & Cichosz, S. L. (2025) · Diabetology · doi:10.3390/diabetology6030017 · Cited by 43
“Despite these challenges, CGM holds promises for improving long-term outcomes in neonatal care [86–88].”
Continuous glucose monitoring for children with hypoglycaemia: Evidence in 2023
Worth, C., Hoskyns, L., Salomon-Estebanez, M., Nutter, P. W., Harper, S., Derks, T. G. J., Beardsall, K., & Banerjee, I. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1116864 · Cited by 29
Self-citation
Metadata
- Authors
- Beardsall, K., Thomson, L., Guy, C., Iglesias-Platas, I., van Weissenbruch, M. M., Bond, S., Allison, A., Kim, S., Petrou, S., Pantaleo, B., Hovorka, R., Dunger, D., Molnar, Z., Barlow, S., Baugh, S., Johnson, K., Uryn, L., Spencer, C., Hubbard, M., Somisetty, S., Adesiyan, O., Kapadia, J., Millar, Y., Gurusamy, K., Bibb, L., Jones, K., Heaver, R., Muthukumar, P., Nichols, A., Johnson, M., Pond, J., Crowley, P., Mellish, C., Shah, D. D., Abraham, M., Vincent, P., Anil kumar, S., Iringan, A., Aninakwa, B., Dalangin-Chalmers, R. A., & de Lange, A.
- Venue
- The Lancet Child & Adolescent Health
- Publisher
- Elsevier BV
- Published
- 2021-04
- Volume
- 5
- Issue
- 4
- Pages
- 265-273
- ISSN
- 2352-4642 (ISSN-L)
- OpenAlex
- W3127748499
- Cited by
- 82
- References
- 4
- FWCI
- 8.72
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Real-time continuous glucose monitoring in preterm infants (REACT): an international, open-label, randomised controlled trial. https://app.cochat.ai/papers/10.1016/s2352-4642(20)30367-9
- The paper
- Beardsall, K., Thomson, L., Guy, C., Iglesias-Platas, I., van Weissenbruch, M. M., Bond, S., Allison, A., Kim, S., Petrou, S., Pantaleo, B., Hovorka, R., Dunger, D., Molnar, Z., Barlow, S., Baugh, S., Johnson, K., Uryn, L., Spencer, C., Hubbard, M., . . . de Lange, A. (2021). Real-time continuous glucose monitoring in preterm infants (REACT): an international, open-label, randomised controlled trial. The Lancet Child & Adolescent Health. https://doi.org/10.1016/s2352-4642(20)30367-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.